Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applications

Overview
This protocol describes the isolation and feeder-cell-based expansion of NK cells. To demonstrate clinical scalability, the method was tested on GMP-grade G-Rex® 100M platforms, achieving clinically relevant numbers of highly pure and functional NK cells suitable for adoptive therapy.
What this paper found
A magnetic negative-selection and feeder-based protocol isolates natural killer cells from human peripheral blood and expands them to numbers relevant for clinical use. Starting from 25 ml of blood, isolation yielded on average 3.1 × 10^6 NK cells, with over 90% viability and close to 99% CD3-CD56+ purity. Cultures received irradiated EBV-LCL feeder cells at a 1:10 NK:feeder ratio, a single dose of 20 ng/ml IL-21 and repeated additions of 500 IU/ml IL-2. Seeding 2 × 10^6 NK cells gave an average of 1.89 × 10^11 cells by day 28, and cytotoxicity against K562 targets was maintained from day 12 to day 28 and after cryopreservation. The method was also tested in G-Rex® 100M flasks to assess scalability.
Note: In vitro study; the authors note that the immunophenotype and function of the expanded NK cells have not been tested in an in vivo setting.
Overall, these results demonstrate that a MACS-based isolation protocol, coupled with the feeder cell-based expansion method with a minimalistic cytokine stimulation is sufficient to generate clinically relevant numbers of highly pure and functional NK cells. — Soumyadipta Kundu, Leonie Durkan, Michael O’Dwyer, Eva Szegezdi, Biology Methods and Protocols
Study details
- Authors
- Soumyadipta Kundu, Leonie Durkan, Michael O’Dwyer, Eva Szegezdi
- Institution
- School of Biological and Chemical Sciences, University of Galway, Galway, Ireland · School of Medicine, University of Galway, Galway, Ireland
- Journal
- Biology Methods and Protocols
- Year
- 2025
- G-Rex® model(s)
- G-Rex®100M
- Cell type(s)
- NK Cells
- Application area
- Hematologic malignancy
- Study phase
- Preclinical
How G-Rex® was used
A 100M G-Rex® culture flask was used to expand EBV-LCL feeder cells: 50 × 10^6 cells were seeded in 1000 ml of complete RPMI medium and incubated for 10 days, with 75% of the medium changed on day 7. For the scalability test, NK cells isolated from 50-60 ml of peripheral blood were seeded in G-Rex® 100M flasks with irradiated EBV-LCL feeder cells at a 1:10 NK:feeder ratio. The flasks were topped up with 1000 ml of complete NK MACS medium containing 500 IU/ml IL-2 and 20 ng/ml IL-21, and IL-2 was added every 48 h from day 2.
Explore related
Full citation
Kundu S, Durkan L, O'Dwyer M, Szegezdi E. Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applications. Biol Methods Protoc. 2025;10(1):bpaf015.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.